MMMikhail Mazurenka

Mikhail Mazurenka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mikhail Mazurenka has a total of 134 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Trimodal system for in vivo skin cancer screening with combined optical coherence tomography‐Raman and colocalized optoacoustic measurements

    by Arthur Varkentin, Mikhail Mazurenka, Elias Blumenröther, Lea Behrendt, Steffen Emmert, Uwe Morgner, Merve Meinhardt‐Wollweber, Maik Rahlves, Bernhard Roth

    A new multimodal system for rapid, noninvasive in vivo skin cancer screening is presented, combining optical coherence tomography (OCT) and optoacoustic (OA) modalities to provide precise tumor depth determination with a Raman spectroscopic modality capable of detecting the lesion type and, thus, providing diagnostic capability. Both OA and Raman setups use wide field skin illumination to ensure the compliance with maximum permissible exposure (MPE) requirements. The Raman signal is collected via the OCT scanning lens to maximize the signal‐to‐noise ratio of the measured signal while keeping radiation levels below MPE limits. OCT is used to optically determine the tumor thickness and for volumetric imaging whereas OA utilizes acoustic signals generated by optical absorption contrast for thickness determination at potentially higher penetration depths compared to OCT. Preliminary results of first clinical trials using our setup are presented. The measured lesion depth is in good agreement with histology results, while Raman measurements show distinctive differences between normal skin and melanocytic lesions, and, moreover, between different skin areas. In future, we will validate the setup presented for reliable detection of pathophysiological parameters, morphology and thickness of suspicious skin lesions.


  • Development of a combined OCT-Raman probe for the prospective in vivo clinical melanoma skin cancer screening

    by M. Mazurenka, L. Behrendt, M. Meinhardt-Wollweber, U. Morgner, B. Roth

    A combined optical coherence tomography (OCT)-Raman probe was designed and built into a spectral domain OCT head, and its performance was evaluated and compared to the most common Raman probe setups, based on a fiber bundle and confocal free space optics. Due to the use of the full field of view of an OCT scanning lens, the combined probe has a superior performance within maximum permissible exposure limits, compared to the other two probes. Skin Raman spectra, recorded in vivo, further prove the feasibility of the OCT-Raman probe for the future in vivo clinical applications in skin cancer screening.


  • Simple model to simulate OCT-depth signal in weakly and strongly scattering homogeneous media

    by Arthur Varkentin, Maya Otte, Merve Meinhardt-Wollweber, Maik Rahlves, Mikhail Mazurenka, Uwe Morgner, Bernhard Roth

    We present a simple and efficient Monte Carlo model to predict the scattering coefficients and the influence of multiple photon scattering with increasing concentration of scattering centers from optical coherence tomography (OCT) data. While the model reliably estimates optical sample parameters for a broad range of concentrations, it does not require inclusion of more complex phenomena such as dependent scattering. Instead, it relies on a particular weighting function which is introduced to describe various orders of multiple scattering events. In weakly scattering homogeneous media the measured scattering coefficient depends linearly on the concentration of scattering centers. In the case of strong scattering, the dependence becomes nonlinear. Our model is able to accurately predict this nonlinearity and can be applied to extend the OCT studies of biological tissue towards determination of optical properties in the future.


  • Open Access

    Characterization of a time-resolved non-contact scanning diffuse optical imaging system exploiting fast-gated single-photon avalanche diode detection

    by Laura Di Sieno, Heidrun Wabnitz, Antonio Pifferi, Mikhail Mazurenka, Yoko Hoshi, Alberto Dalla Mora, Davide Contini, Gianluca Boso, Wolfgang Becker, Fabrizio Martelli, et al.

    We present a system for non-contact time-resolved diffuse reflectance imaging, based on small source-detector distance and high dynamic range measurements utilizing a fast-gated single-photon avalanche diode. The system is suitable for imaging of diffusive media without any contact with the sample and with a spatial resolution of about 1 cm at 1 cm depth. In order to objectively assess its performances, we adopted two standardized protocols developed for time-domain brain imagers. The related tests included the recording of the instrument response function of the setup and the responsivity of its detection system. Moreover, by using liquid turbid phantoms with absorbing inclusions, depth-dependent contrast and contrast-to-noise ratio as well as lateral spatial resolution were measured. To illustrate the potentialities of the novel approach, the characteristics of the non-contact system are discussed and compared to those of a fiber-based brain imager.


  • Time-Domain Diffuse Optical Imaging of Tissue by Non-contact Scanning

    by Heidrun Wabnitz, Mikhail Mazurenka, Laura Di Sieno, Gianluca Boso, Wolfgang Becker, Katja Fuchs, Davide Contini, Alberto Dalla Mora, Alberto Tosi, Rainer Macdonald, et al.


  • Open Access

    Performance assessment of time-domain optical brain imagers, part 1: basic instrumental performance protocol

    by Heidrun Wabnitz, Dieter Richard Taubert, Mikhail Mazurenka, Oliver Steinkellner, Alexander Jelzow, Rainer Macdonald, Daniel Milej, Piotr Sawosz, Michal Kacprzak, Adam Liebert, et al.

    In recent years, instruments and methodologies to noninvasively probe human tissues by diffuse light in the near-infrared spectral range have undergone translation from laboratory bench to bedside. For example, clinical trials have been performed targeting the female breast. Optical mammography has been developed and applied to detect and characterize breast lesions,1,2 as well as to monitor the outcome of neoadjuvant chemotherapy of the breast.3,4 Diffuse optical spectroscopy is a promising technique for cancer risk assessment.5,6 In parallel, many clinical studies have been conducted targeting the brain. Optical imaging has been used to observe the hemodynamic response to cognitive, sensory, and motor stimuli,7 and to assess changes associated with traumatic brain injury,8 stroke,9 and epilepsy,10 with the aim of providing a less expensive and portable alternative to the existing neuroimaging techniques such as magnetic resonance imaging or x-ray computed tomography. Meanwhile, optical techniques have also been applied to other tissues such as muscle, joints, bone, and skin as a means of providing diagnostic information.


  • Open Access

    Performance assessment of time-domain optical brain imagers, part 2: nEUROPt protocol

    by Heidrun Wabnitz, Alexander Jelzow, Mikhail Mazurenka, Oliver Steinkellner, Rainer Macdonald, Daniel Milej, Norbert Zolek, Michal Kacprzak, Piotr Sawosz, Roman Maniewski, et al.

    In biomedical optics, the characterization of instrumentation with the help of appropriate tissue-simulating phantoms1 plays an important role, ranging from proof-of-principle tests at early stages of the development to quality assurance during routine clinical application.2 Numerous performance studies have been carried out by individual research groups; however, there are only a few multilaboratory efforts to characterize and to compare multiple instruments. Such approaches are essential to provide a sound basis for achieving quantitatively comparable results in clinical studies. They require the development of standardized guidelines to perform the same measurements on phantoms with the same properties in different laboratories. In the field of photon migration instruments, the first systematic study of different instruments was performed on the basis of the MEDPHOT protocol.3 Recently, the development and testing of phantoms has been reported for quality assurance in a multicenter clinical trial to measure the response of breast tumors to neoadjuvant chemotherapy by means of diffuse optical spectroscopic imaging.4 In the context of fluorescence imaging of tissues, phantoms were developed to characterize and compare imaging systems and to train surgeons.5


  • Open Access

    Phantoms for diffuse optical imaging based on totally absorbing objects, part 2: experimental implementation

    by Fabrizio Martelli, Paola Di Ninni, Giovanni Zaccanti, Davide Contini, Lorenzo Spinelli, Alessandro Torricelli, Rinaldo Cubeddu, Heidrun Wabnitz, Mikhail Mazurenka, Rainer Macdonald, et al.

    In this paper, we present the experimental implementation for a concept for the construction of inhomogeneous phantoms for imaging in diffuse media based on totally absorbing objects that was proposed in the previous companion paper.1 This work stems from the outcome of a large collaboration among seven institutions from four countries within the framework of the European nEUROPt Project that put great emphasis on standardization approaches to assess the performance of noninvasive optical brain imagers. The key motivation for these activities is that, while the investigation of the human body by diffusely propagated light has brought a wealth of different techniques and applications2 (e.g., optical mammography,3 4. – 5 neoadjuvant chemotherapy monitoring,6 breast cancer risk assessment,7 brain functional imaging,2,8,9 neuromonitoring,10 muscle oximetry,11 study of epilepsy,12,13 investigation of bone and joint pathologies,14 and photodynamic therapy dosimetry15), there is still a compelling need for standardization and quality assessment of instruments to bring the whole field to a clinically mature stage.16 Indeed, the large variety of techniques and instruments addressing diverse clinical problems demand some clearly identified and shared procedures to test and validate the optical systems. Common standardization tools help in comparing results obtained in different clinical studies, permit one to grade different instruments’ performances or subsequent upgrades of the same system, and address the research—particularly at the industrial level—toward those parameters that best match the clinical needs. This process necessarily passes through the proposition of good reproducible and reliable phantoms and procedures, the buildup of a widespread consensus in the scientific community and, at last, the adoption of good laboratory practices and formalization by standardization bodies. Clearly, the availability of well characterized, reliable, reproducible, and realistic phantoms is essential for this process. Concerning homogeneous phantoms, the status is quite advanced, with many tested options,17 18. 19. 20. 21. 22. 23. – 24 off-the-shelf solid phantoms with well characterized and documented optical properties,25 and good agreement in liquid phantoms’ characterization in multilaboratory studies.26 Conversely, the situation of inhomogeneous phantoms is less consolidated due to many criticalities and large combinations of geometries and optical properties. Different approaches have been proposed. Without claiming to give a comprehensive review of the whole field here—more information can be gathered in the review papers24,27 and a recent special issue of Biomed. Opt. Express16—we just recall that three schemes can be adopted for this purpose, namely liquid–liquid,28 liquid–solid,29 30. – 31 and solid–solid32 33. – 34 structures, each of them with different advantages and criticalities. Liquid–liquid phantoms realize inhomogeneous properties by embedding a liquid solution (typically based on intralipid and ink) in a small cell—made of glass, thin plastic, or latex—suspended within another homogeneous solution. The advantages are the great flexibility and the reliability in the choice of optical properties, the possibility to move the inclusion within the medium, and also to realize a purely homogeneous reference state. Conversely, the main concerns are the possible light guiding effects in the small cell walls, the challenging fabrication and the exact placement of soft-flexible objects, the great perturbation produced by transparent walls in the measurement tank for reflectance measurements,35 and generally the complex handling procedures in routine clinical settings. The liquid–solid approach replaces the liquid perturbation with a solid one crafted from a solid phantom or from a liquid phantom solidified with the addition of a hardener, e.g., agar32 or polyacrylamide.31 In this case, the handling and the replacement of the perturbation is easier, and light-guiding effects are avoided. On the other hand, the exact matching of optical properties is not trivial due to the application of two-different phantom recipes, the fact that the hardener may change the inclusion properties,32 and the refractive index mismatch between the solid inclusion and its surroundings has to be considered. Solid–solid structures are definitely the best solution for routine use in clinics and also as a fast and reliable option in the laboratory. Yet, the fabrication of such phantoms is not straightforward. It is not possible to replace or move the perturbation, and it is not trivial to precisely measure the optical properties of the inclusion. Among this class, one can also mention electrically activated phantoms where a local increase in the absorption properties is produced by localized heating of targets impregnated with thermochromic pigment33 or liquid-crystal–based dynamic phantom for quality assurance of functional near-infrared spectroscopy devices.36 Dynamic changes can be easily achieved with such a rugged solid phantom, yet exact control and reproducibility are still an issue.


  • Open Access

    Determination of reference values for optical properties of liquid phantoms based on Intralipid and India ink

    by L. Spinelli, M. Botwicz, N. Zolek, M. Kacprzak, D. Milej, P. Sawosz, A. Liebert, U. Weigel, T. Durduran, F. Foschum, et al.

    A multi-center study has been set up to accurately characterize the optical properties of diffusive liquid phantoms based on Intralipid and India ink at near-infrared (NIR) wavelengths. Nine research laboratories from six countries adopting different measurement techniques, instrumental set-ups, and data analysis methods determined at their best the optical properties and relative uncertainties of diffusive dilutions prepared with common samples of the two compounds. By exploiting a suitable statistical model, comprehensive reference values at three NIR wavelengths for the intrinsic absorption coefficient of India ink and the intrinsic reduced scattering coefficient of Intralipid-20% were determined with an uncertainty of about 2% or better, depending on the wavelength considered, and 1%, respectively. Even if in this study we focused on particular batches of India ink and Intralipid, the reference values determined here represent a solid and useful starting point for preparing diffusive liquid phantoms with accurately defined optical properties. Furthermore, due to the ready availability, low cost, long-term stability and batch-to-batch reproducibility of these compounds, they provide a unique fundamental tool for the calibration and performance assessment of diffuse optical spectroscopy instrumentation intended to be used in laboratory or clinical environment. Finally, the collaborative work presented here demonstrates that the accuracy level attained in this work for optical properties of diffusive phantoms is reliable.


  • Open Access

    Non-contact in vivo diffuse optical imaging using a time-gated scanning system

    by M. Mazurenka, L. Di Sieno, G. Boso, D. Contini, A. Pifferi, A. Dalla Mora, A. Tosi, H. Wabnitz, R. Macdonald

    We report on the design and first in vivo tests of a novel non-contact scanning imaging system for time-domain near-infrared spectroscopy. Our system is based on a null source-detector separation approach and utilizes polarization-selective detection and a fast-gated single-photon avalanche diode to record late photons only. The in-vivo tests included the recording of hemodynamics during arm occlusion and two brain activation tasks. Localized and non-localized changes in oxy- and deoxyhemoglobin concentration were detected for motor and cognitive tasks, respectively. The tests demonstrate the feasibility of non-contact imaging of absorption changes in deeper tissues.